AIM ImmunoTech Inc. (AIM) Form 424B3 — Jun 24, 2026
AIM ImmunoTech filed a prospectus relating to the resale of up to 13,077,089 shares of common stock by selling stockholders. These shares, stemming from a June 2026 registered direct offering and private placement, represent approximately 47.17% of the company's issued and outstanding common stock prior to this offering, creating a significant potential dilution overhang. The securities being resold include PIPE shares, pre-funded warrants, and Class J warrants, with the original offering price set at $0.5189 per share. This contrasts with the last reported sale price of $0.36 per share on June 23, 2026.
Key figures
- Offering Price
- $0.5189
- Shares Offered
- 13,077,089
- Shares Outstanding
- 27,724,245
- Current Market Price
- $0.36
- Dilution Percentage
- 47.17%
- Potential Warrant Proceeds
- $5.5 million
- Registered Direct Proceeds
- $1.3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.